To follow

Project leadership and coordination - Stakeholder engagement - Community development - Dissemination - Strategic Communications. Life Sciences - EU funded programmes - Public-Private Partnerships - Research Consortia - Science-based start-ups.

Funded by the Innovative Medicines Initiative (IMI) / Innovative Health Initiative (IHI)HARMONY | 128+ Partners, Associated Members, Patientcluster | 28 countries | Euro 40 million | January 2017-June 2023 HARMONY PLUS | 40+ Partners, Associated Partners | Euro 11,8 million | October 2020-March 2024www.harmony-alliance.eu | @HarmonynetEU | #bigdataforbloodcancerRepresenting HARMONY Partner: the European Hematology Association (www.ehaweb.org)HARMONY: European Public-Private Partnership for Big Data in Hematology. Uniting academic institutions, national clinical disease networks, European organizations, patient advocacy groups, clinicians, and pharmaceutical companies, as well as regulatory agencies, experts in economics and ethics, and information and technology specialists. HARMONY aims to unlock valuable knowledge across the spectrum of over 14 blood cancers to accelerate better treatment of patients.

Starting up a company requires not only a good idea and lots of enthusiasm, but also involves often a long difficult development path with many hurdles. In life sciences taking an invention from the lab to the market typically takes 5 to 10 years and requires several tenths of millions of euros of investment. In case of a new drug this can even take as long as 15 years and cost up to a billion euros.LifeSciences@work [LS@W] helps to overcome these hurdles by bringing together programmes such as:the Venture Challenge, Expert Classes and the Value Centre.LS@W has a special focus on Life Sciences researchers with entrepreneur aspirations. LS@W will continue to nurture the start-up community in which experts, past, present and future entrepreneurs are united.

2nd Transatlantic Conference on Personalized Medicine Aligning all dimensions of P4 medicine: personalized, preventive, predictive, participatory.8 & 9 October 2015, Erasmus MC, Rotterdam, The Netherlandswww.personalizedmed.eu | @PmedEUWhile science and technology are rapidly introducing new possibilities, major changes are set in motion by an increasing participation of patients and consumers. The Transatlantic Conference on Personalized Medicine (TCPM2015) will bring together opinion leaders and decision makers from science, society, health care, policy and industry with the aim of creating transatlantic and European platforms and pathways for introducing applications of personalized medicine in prevention, cure and care.TCPM2015 focuses on knowledge valorization and consortium building within the international science policy frameworks. Themes include; 'Diabesity'; Value Based Health Care; Cardiovascular & Womens' Health, Public Private Partnerships; Global perspective in PMed.

www.eurobioforum.eu | for research funders and performers in Personalised Medicine Funded by the European Commission (DG Research & Innovation), 7th Framework Programme. Duration: 1 January 2011 – 31 December 2014Scout > Connect > Activate: we bring people and parties together, to assure the position of Europe as the research and implementation capital of Personalised Medicine, all for the benefit of the patient. Driven by ‘personal participation’, EuroBioForum activities are grouped into three main components: Annual meetings – EuroBioForum 2012, 2013, 2014; Personalised Medicine Observatory; Online community.

25+ years of COMMUNICATING SCIENCE: Publimarket was a communications consultancy specialised in strategy development and execution. The continuous stream of innovations and scientific insights was the inspiration for our work and the core of our interest. We advised consortium's, companies and institutes on appropriate strategies and tools to identify and engage with stakeholders, disseminate scientific results and build communities. Working areas: life sciences, healthcare, nanotechnology, bioinformatics, sustainable energy and international law.

Responsible for all NGI communications strategies and the total 'package' of corporate communications from the start in 2002 untill 2013. Communication advise and communication coaching of new NGI Genomics Centres of Excellence (16).Conceptualization of the LifeSciences@Work programme, the NGI valorisation activities for academic start-ups.Conceptualization and realization of annual assemblies i.e. Genomics/Life Sciences Momentum (12 editions): 2012 Communicating Science / 2011: Science for Society / 2010: Global Connections / 2009: Empowering the future / 2008: Focus on Value / 2007: Eye on genomics / 2006: Genomics: Ready for the next step / 2005: Genomics in the here and now: Emerging benefits for health / 2004: Genomics for our world / 2003: Industrial Innovation / 2002: Create your own Momentum / 2001: Update & Impuls.Event development of various special interest Meetings.Through Publimarket communications consultancy and management services have been offered from 2002 until the end of NGI in December 2013.Netherlands Genomics Initiative (NGI) | www.genomics.nl | has created societal and economic value from genomics through a network of large-scale Genomics Centres that work on targeted programmes. These centres are/were consortiums of universities, research institutes, industry and societal organisations and cover/covered the complete chain from basic science to applied research, development and finally valorisation of the results. Societal embedding and creating new economic activity was an integral part of the programme of each consortium. NGI was funded by 5 Dutch Ministries was affiliated to AgentschapNL; Netherlands Organisation for Scientific Research (NWO); Technology Foundation STW.

www.hiil.org | www.innovatingjustice.com